Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TH.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
May 31, 2025 -38.39M
February 28, 2025 -35.25M
November 30, 2024 -35.38M
August 31, 2024 -26.52M
May 31, 2024 -31.64M
February 29, 2024 -33.37M
November 30, 2023 -28.30M
August 31, 2023 -56.42M
May 31, 2023 -56.45M
February 28, 2023 -43.99M
November 30, 2022 -30.60M
August 31, 2022 -23.65M
May 31, 2022 -14.73M
February 28, 2022 12.89M
November 30, 2021 22.78M
August 31, 2021 33.96M
May 31, 2021 42.48M
February 28, 2021 51.15M
November 30, 2020 4.178M
August 31, 2020 11.11M
May 31, 2020 21.32M
February 29, 2020 27.74M
November 30, 2019 32.99M
August 31, 2019 39.89M
May 31, 2019 42.39M
Date Value
February 28, 2019 44.94M
November 30, 2018 46.54M
August 31, 2018 46.36M
May 31, 2018 39.20M
February 28, 2018 40.43M
November 30, 2017 43.12M
August 31, 2017 45.67M
May 31, 2017 45.18M
February 28, 2017 39.86M
November 30, 2016 26.89M
August 31, 2016 25.81M
May 31, 2016 24.63M
February 29, 2016 20.19M
November 30, 2015 20.02M
August 31, 2015 19.19M
May 31, 2015 8.401M
February 28, 2015 7.595M
November 30, 2014 7.868M
August 31, 2014 11.49M
May 31, 2014 15.91M
February 28, 2014 14.96M
November 30, 2013 18.53M
August 31, 2013 21.11M
May 31, 2013 23.08M
February 28, 2013 24.55M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Spectral Medical, Inc. -70.07M
Resverlogix Corp. -133.75M
COSCIENS Biopharma, Inc. 21.06M
Restart Life Sciences Corp. 1.543M
Defence Therapeutics Inc 5.415M

Shareholders Equity (Quarterly) Related Metrics